T1	Participants 60 94	patients with head and neck cancer
T2	Participants 164 204	patients with head and neck cancer (HNC)
T3	Participants 768 801	21 RTOG HNC trials (1997 to 2002)
T4	Participants 996 1036	471 patients in RTOG 0129 (2002 to 2005)
